Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Biotricity surpasses 2B recorded, analyzed heartbeats for AFib » 08:48
10/04/22
10/04
08:48
10/04/22
08:48
BTCY

Biotricity

/

+

Biotricity announced a…

Biotricity announced a significant milestone of recording and analyzing over 2 billion heartbeats for Atrial Fibrillation, the most common type of cardiac arrhythmia and a leading cause of stroke. Bioflux, Biotricity's high-precision, single-unit mobile cardiac telemetry device that provides real-time monitoring and transmission of the patient's ECG information, has captured billions of heartbeats to date, monitored in real-time by Bioflux's built in algorithms, certified cardiac technicians and benchmarked by Artificial Intelligence. Leveraging the Company's proprietary AI, over 2 billion of the total heartbeats to date have been segmented for AFib analysis. According to Emergen Research, the global recurrent market for AFib is expected to reach USD$26 billion by 2027, growing at a CAGR of 13.2%. This large data set provides further benefits for patients, providers and ultimately clinical research for the future of predictive monitoring. Additionally, it allows Biotricity to scale faster and operate more efficiently, develop better automation, yielding growth and better margins in the future. The consistent focus on R&D and data capture has positioned Biotricity with a significant competitive advantage in key cardiac segments of the market, such as AFib.

ShowHide Related Items >><<
BTCY Biotricity
/

+

BTCY Biotricity
/

+

07/15/22 Lake Street
Biotricity price target lowered to $4 from $5 at Lake Street
07/15/22 Maxim
Biotricity downgraded to Hold from Buy at Maxim
03/07/22 Lake Street
Biotricity initiated with a Buy at Lake Street
11/23/21 H.C. Wainwright
Biotricity initiated with a Buy at H.C. Wainwright
BTCY Biotricity
/

+

BTCY Biotricity
/

+

Over a week ago
Hot Stocks
Biotricity wins NIH grant for AI-enabled real-time monitoring, predictive analyt » 08:38
09/07/22
09/07
08:38
09/07/22
08:38
BTCY

Biotricity

$1.01 /

-0.08 (-7.34%)

Biotricity announced that…

Biotricity announced that it will be carrying out an NIH-sponsored Phase I study of Bioflux-AI, Biotricity's innovative artificial intelligence-driven system of real-time monitoring and prediction technology, in subjects with Chronic Kidney Disease. The risk of ischemic and hemorrhagic stroke is 5 to 30 times higher in patients with CKD and has a mortality rate of up to three times that of the general population. Effective stroke risk prediction is currently flawed in CKD patients because comorbidities often remain undiagnosed and stroke risk stratification schemes do not consider stages of CKD. Additionally, the detection of stroke-risk variations due to dialysis requires real-time risk monitoring, which is unavailable to date.

ShowHide Related Items >><<
BTCY Biotricity
$1.01 /

-0.08 (-7.34%)

BTCY Biotricity
$1.01 /

-0.08 (-7.34%)

07/15/22 Lake Street
Biotricity price target lowered to $4 from $5 at Lake Street
07/15/22 Maxim
Biotricity downgraded to Hold from Buy at Maxim
03/07/22 Lake Street
Biotricity initiated with a Buy at Lake Street
11/23/21 H.C. Wainwright
Biotricity initiated with a Buy at H.C. Wainwright
BTCY Biotricity
$1.01 /

-0.08 (-7.34%)

BTCY Biotricity
$1.01 /

-0.08 (-7.34%)

Over a month ago
Recommendations
Biotricity price target lowered to $4 from $5 at Lake Street » 09:12
07/15/22
07/15
09:12
07/15/22
09:12
BTCY

Biotricity

$1.38 /

-0.02 (-1.43%)

Lake Street analyst Frank…

Lake Street analyst Frank Takkinen lowered the firm's price target on Biotricity to $4 from $5 and keeps a Buy rating on the shares after the company reported fiscal Q4 results, stating that he believes Biotricity has "made solid fundamental progress toward becoming the one-stop-shop platform for complex cardiac care." His lower target reflects market-wide multiple contraction, Takkinen noted.

ShowHide Related Items >><<
BTCY Biotricity
$1.38 /

-0.02 (-1.43%)

BTCY Biotricity
$1.38 /

-0.02 (-1.43%)

07/15/22 Maxim
Biotricity downgraded to Hold from Buy at Maxim
03/07/22 Lake Street
Biotricity initiated with a Buy at Lake Street
11/23/21 H.C. Wainwright
Biotricity initiated with a Buy at H.C. Wainwright
BTCY Biotricity
$1.38 /

-0.02 (-1.43%)

BTCY Biotricity
$1.38 /

-0.02 (-1.43%)

Downgrade
Biotricity downgraded to Hold from Buy at Maxim » 08:33
07/15/22
07/15
08:33
07/15/22
08:33
BTCY

Biotricity

$1.38 /

-0.02 (-1.43%)

Maxim analyst Allen Klee…

Maxim analyst Allen Klee downgraded Biotricity to Hold from Buy after its Q4 results, noting that while the company beat on the top line, he is cutting his estimates to reflect slower adoption. The analyst also sees the risk-reward on the stock as balanced at current levels, with headwinds that include inflationary pressures restricting doctor's discretionary spending, COVID-19, vacation policies reducing doctor usage, and delays in integration times for new products.

ShowHide Related Items >><<
BTCY Biotricity
$1.38 /

-0.02 (-1.43%)

BTCY Biotricity
$1.38 /

-0.02 (-1.43%)

03/07/22 Lake Street
Biotricity initiated with a Buy at Lake Street
11/23/21 H.C. Wainwright
Biotricity initiated with a Buy at H.C. Wainwright
BTCY Biotricity
$1.38 /

-0.02 (-1.43%)

BTCY Biotricity
$1.38 /

-0.02 (-1.43%)

On The Fly
What You Missed On Wall Street This Morning » 12:03
07/14/22
07/14
12:03
07/14/22
12:03
JPM

JPMorgan

$107.85 /

-4.135 (-3.69%)

, MS

Morgan Stanley

$74.61 /

-0.32 (-0.43%)

, AMZN

Amazon.com

$109.32 /

-1.09 (-0.99%)

, TWTR

Twitter

$36.42 /

-0.32 (-0.87%)

, COST

Costco

$504.42 /

+12.09 (+2.46%)

, AMD

AMD

$77.60 /

+0.12 (+0.15%)

, CAG

Conagra Brands

$32.88 /

-2.84 (-7.95%)

, TSM

TSMC

$82.57 /

+1.3 (+1.60%)

, FFIV

F5 Networks

$145.47 /

-4.09 (-2.73%)

, DG

Dollar General

$247.82 /

+1.28 (+0.52%)

, MSFT

Microsoft

$251.34 /

-1.37 (-0.54%)

, ATEC

Alphatec

$6.50 /

-0.285 (-4.20%)

, BP

BP

$25.87 /

-1.14 (-4.22%)

, CS

Credit Suisse

$5.15 /

-0.22 (-4.10%)

, DB

Deutsche Bank

$7.70 /

-0.105 (-1.35%)

, GRBK

Green Brick

$23.55 /

+1.83 (+8.43%)

, GOEV

Canoo

$4.59 /

+1.005 (+28.07%)

, BLU

Bellus Health

$8.93 /

-1.165 (-11.54%)

, ILPT

Industrial Logistics Property Trust

$10.66 /

-3.38 (-24.07%)

, EGY

Vaalco Energy

$5.26 /

-0.97 (-15.57%)

, TGA

TransGlobe

$3.39 /

+0.21 (+6.60%)

, ERIC

Ericsson

$6.84 /

-0.655 (-8.74%)

, CTAS

Cintas

$383.87 /

+5.555 (+1.47%)

, THTX

Theratechnologies

$2.29 /

+0.24 (+11.71%)

, PCRX

Pacira

$51.83 /

-2.19 (-4.05%)

, BTCY

Biotricity

$1.35 /

-0.05 (-3.57%)

Get caught up quickly on…

ShowHide Related Items >><<
TWTR Twitter
$36.42 /

-0.32 (-0.87%)

TSM TSMC
$82.57 /

+1.3 (+1.60%)

THTX Theratechnologies
$2.29 /

+0.24 (+11.71%)

PCRX Pacira
$51.83 /

-2.19 (-4.05%)

MSFT Microsoft
$251.34 /

-1.37 (-0.54%)

MS Morgan Stanley
$74.61 /

-0.32 (-0.43%)

JPM JPMorgan
$107.85 /

-4.135 (-3.69%)

ILPT Industrial Logistics Property Trust
$10.66 /

-3.38 (-24.07%)

GRBK Green Brick
$23.55 /

+1.83 (+8.43%)

GOEV Canoo
$4.59 /

+1.005 (+28.07%)

FFIV F5 Networks
$145.47 /

-4.09 (-2.73%)

ERIC Ericsson
$6.84 /

-0.655 (-8.74%)

EGY Vaalco Energy
$5.26 /

-0.97 (-15.57%)

DG Dollar General
$247.82 /

+1.28 (+0.52%)

DB Deutsche Bank
$7.70 /

-0.105 (-1.35%)

CS Credit Suisse
$5.15 /

-0.22 (-4.10%)

COST Costco
$504.42 /

+12.09 (+2.46%)

CAG Conagra Brands
$32.88 /

-2.84 (-7.95%)

BTCY Biotricity
$1.35 /

-0.05 (-3.57%)

BP BP
$25.87 /

-1.14 (-4.22%)

BLU Bellus Health
$8.93 /

-1.165 (-11.54%)

ATEC Alphatec
$6.50 /

-0.285 (-4.20%)

AMZN Amazon.com
$109.32 /

-1.09 (-0.99%)

AMD AMD
$77.60 /

+0.12 (+0.15%)

JPM JPMorgan
$107.85 /

-4.135 (-3.69%)

07/12/22 Morgan Stanley
JPMorgan price target lowered to $127 from $149 at Morgan Stanley
07/12/22 Citi
JPMorgan upgraded to Buy from Neutral at Citi
07/11/22 Jefferies
JPMorgan price target lowered to $126 from $137 at Jefferies
07/01/22 Oppenheimer
Oppenheimer says U.S. financial institutions 'dramatically undervalued'
MS Morgan Stanley
$74.61 /

-0.32 (-0.43%)

07/05/22 Credit Suisse
Morgan Stanley price target lowered to $95 from $100 at Credit Suisse
07/01/22 Piper Sandler
Morgan Stanley price target lowered to $90 from $100 at Piper Sandler
06/28/22 RBC Capital
Morgan Stanley price target lowered to $80 from $97 at RBC Capital
AMZN Amazon.com
$109.32 /

-1.09 (-0.99%)

07/14/22 Cowen
Amazon.com price target lowered to $210 from $215 at Cowen
07/14/22 Citi
Amazon.com price target lowered to $180 from $205 at Citi
07/13/22 Evercore ISI
Evercore downgrades Hanesbrands on reversion in consumer spending
07/13/22 BofA
Veritone downgraded to Neutral at BofA on Amazon automation risk
TWTR Twitter
$36.42 /

-0.32 (-0.87%)

07/14/22 Rosenblatt
Twitter upgraded to Buy from Neutral at Rosenblatt
07/14/22 Rosenblatt
Twitter upgraded to Buy from Neutral at Rosenblatt
07/13/22 GLJ Research
Musk's 'serious legal jeopardy' could drop Tesla shares by 68%, says GLJ
07/13/22 Wedbush
Twitter files suit against Musk in 'horror movie with no winners,' says Wedbush
COST Costco
$504.42 /

+12.09 (+2.46%)

07/14/22 Deutsche Bank
Deutsche Bank upgrades Costco ahead of 'meaningful share gains'
07/14/22 Deutsche Bank
Costco upgraded to Buy from Hold at Deutsche Bank
07/08/22 Baird
Costco sales remain healthy with no slowdown seen, says Baird
06/09/22 Atlantic Equities
Costco comp momentum to offset margin pressure, says Atlantic Equities
AMD AMD
$77.60 /

+0.12 (+0.15%)

07/14/22 BMO Capital
AMD upgraded to Outperform from Market Perform at BMO Capital
07/13/22 Susquehanna
AMD price target lowered to $120 from $140 at Susquehanna
07/12/22 Cowen
AMD price target lowered to $120 from $160 at Cowen
07/12/22 KeyBanc
AMD price target lowered to $130 from $150 at KeyBanc
CAG Conagra Brands
$32.88 /

-2.84 (-7.95%)

03/30/22 UBS
Conagra Brands initiated with a Neutral at UBS
01/11/22 Morgan Stanley
Conagra Brands price target raised to $36 from $35 at Morgan Stanley
01/07/22 Deutsche Bank
Conagra Brands price target lowered to $35 from $36 at Deutsche Bank
10/08/21 JPMorgan
Conagra downgraded on limited earnings upside at JPMorgan
TSM TSMC
$82.57 /

+1.3 (+1.60%)

07/14/22 Susquehanna
TSMC price target lowered to $88 from $90 at Susquehanna
07/12/22 Citi
Citi sees estimate upside, 'upbeat' Q2 from TSMC
06/21/22 Loop Capital
TSMC initiated with a Buy at Loop Capital
06/09/22 Susquehanna
TSMC on track to meet/exceed guidance, says Susquehanna
FFIV F5 Networks
$145.47 /

-4.09 (-2.73%)

07/14/22 JPMorgan
F5 Networks downgraded to Neutral from Overweight at JPMorgan
07/14/22 Citi
F5 Networks price target lowered to $170 from $210 at Citi
07/14/22 Credit Suisse
F5 Networks downgraded to Neutral from Outperform at Credit Suisse
07/13/22 Piper Sandler
F5 Networks downgraded to Neutral from Overweight at Piper Sandler
DG Dollar General
$247.82 /

+1.28 (+0.52%)

07/14/22 Citi
Dollar General downgraded on balanced risk/reward at Citi
07/14/22 Citi
Dollar General downgraded to Neutral from Buy at Citi
07/05/22 Cleveland Research
Dollar General upgraded to Buy from Neutral at Cleveland Research
06/16/22 Morgan Stanley
Dollar General upgraded to Overweight from Equal Weight at Morgan Stanley
MSFT Microsoft
$251.34 /

-1.37 (-0.54%)

07/14/22 Stephens
Stephens says Netflix choice may leave 'no economics' for Trade Desk, Magnite
07/12/22 Morgan Stanley
Microsoft price target lowered to $354 from $372 at Morgan Stanley
07/08/22 Piper Sandler
Microsoft price target lowered to $312 from $352 at Piper Sandler
07/07/22 Needham
GitLab initiated with Buy, $70 price target at Needham
ATEC Alphatec
$6.50 /

-0.285 (-4.20%)

05/06/22 H.C. Wainwright
Alphatec price target raised to $20 from $19 at H.C. Wainwright
04/19/22 Stifel
J&J notes more-positive Q1 trends, U.S. Spine 'a relative outlier,' says Stifel
04/19/22 Piper Sandler
Piper Sandler continues to recommend exposure to medtech space after J&J results
03/02/22 Piper Sandler
Alphatec price target lowered to $17 from $22 at Piper Sandler
BP BP
$25.87 /

-1.14 (-4.22%)

07/06/22 Deutsche Bank
BP price target raised to 472 GBp from 450 GBp at Deutsche Bank
07/01/22 Jefferies
TotalEnergies upgraded to Buy from Hold at Jefferies
06/09/22 Credit Suisse
BP initiated with a Neutral at Credit Suisse
06/09/22 Credit Suisse
BP initiated with a Neutral at Credit Suisse
CS Credit Suisse
$5.15 /

-0.22 (-4.10%)

07/13/22 Morgan Stanley
Credit Suisse downgraded to Underweight from Equal Weight at Morgan Stanley
06/23/22 Redburn
Credit Suisse downgraded to Sell from Neutral at Redburn
06/09/22 JPMorgan
State Street acquiring Credit Suisse a 'non-starter,' says JPMorgan
06/09/22 Citi
Citi says State Street buying Credit Suisse 'very low probability event'
DB Deutsche Bank
$7.70 /

-0.105 (-1.35%)

07/05/22 JPMorgan
Deutsche Bank price target lowered to EUR 13 from EUR 15 at JPMorgan
04/29/22 UBS
Deutsche Bank price target raised to EUR 16.30 from EUR 15.30 at UBS
04/28/22 RBC Capital
Deutsche Bank price target raised to EUR 13 from EUR 12.50 at RBC Capital
04/21/22 Morgan Stanley
Deutsche Bank price target lowered to EUR 14.90 at Morgan Stanley
GRBK Green Brick
$23.55 /

+1.83 (+8.43%)

07/12/22 JPMorgan
Green Brick price target lowered to $17.50 from $21 at JPMorgan
06/16/22 B. Riley
Green Brick downgraded to Neutral from Buy at B. Riley
04/13/22 JPMorgan
Green Brick price target lowered to $18.50 from $20 at JPMorgan
04/06/22 B. Riley
Green Brick price target lowered to $25 from $27 at B. Riley
GOEV Canoo
$4.59 /

+1.005 (+28.07%)

07/14/22 R.F. Lafferty
Canoo price target lowered to $17 from $20 at R.F. Lafferty
07/13/22 H.C. Wainwright
Canoo price target lowered to $10 from $15 at H.C. Wainwright
12/16/21 R.F. Lafferty
Canoo price target raised to $21 from $19 at R.F. Lafferty
12/16/21 Roth Capital
Roth Capital upgrades Canoo to Buy, raises price target to $14
BLU Bellus Health
$8.93 /

-1.165 (-11.54%)

07/13/22 RBC Capital
Bellus Health price target raised to $19 from $14 at RBC Capital
07/12/22 H.C. Wainwright
H.C. Wainwright says Bellus set for 'show down' against Merck's gefapixant
02/24/22 H.C. Wainwright
Bellus Health price target raised to $16 from $14 at H.C. Wainwright
12/14/21 BTIG
Bellus Health price target raised to $18 from $13 at BTIG
ILPT Industrial Logistics Property Trust
$10.66 /

-3.38 (-24.07%)

05/18/22 JMP Securities
Industrial Logistics Property Trust downgraded to Market Perform from Outperform at JMP Securities
04/29/22 B. Riley
Industrial Logistics price target lowered to $28 from $30 at B. Riley
03/04/22 B. Riley
Industrial Logistics price target lowered to $30 from $35 at B. Riley
11/26/21 RBC Capital
Industrial Logistics Property Trust price target lowered to $25 from $28 at RBC Capital
EGY Vaalco Energy
$5.26 /

-0.97 (-15.57%)

TGA TransGlobe
$3.39 /

+0.21 (+6.60%)

01/28/22 Canaccord
TransGlobe price target raised to 375 GBp from 365 GBp at Canaccord
11/04/21 Canaccord
TransGlobe price target raised to 320 GBp from 295 GBp at Canaccord
09/29/21 Canaccord
TransGlobe price target raised to 280 GBp from 275 GBp at Canaccord
ERIC Ericsson
$6.84 /

-0.655 (-8.74%)

06/10/22 Craig-Hallum
Vonage downgraded to Sell from Hold at Craig-Hallum
04/20/22 Credit Suisse
Ericsson price target lowered to SEK 120 from SEK 134 at Credit Suisse
04/20/22 Barclays
Ericsson price target lowered to SEK 130 from SEK 160 at Barclays
04/18/22 Cowen
Ericsson price target lowered to $15 from $16 at Cowen
CTAS Cintas
$383.87 /

+5.555 (+1.47%)

07/12/22 Wells Fargo
Cintas initiated with an Equal Weight at Wells Fargo
07/05/22 Deutsche Bank
Cintas price target lowered to $465 from $517 at Deutsche Bank
03/29/22 Deutsche Bank
Cintas initiated with a Buy at Deutsche Bank
03/25/22 Argus
Cintas price target lowered to $450 from $490 at Argus
THTX Theratechnologies
$2.29 /

+0.24 (+11.71%)

07/29/21 Canaccord
Theratechnologies downgraded to Hold from Buy at Canaccord
PCRX Pacira
$51.83 /

-2.19 (-4.05%)

03/01/22 Northland
Pacira price target raised to $67 from $61 at Northland
02/25/22 H.C. Wainwright
Pacira price target raised to $90 from $86 at H.C. Wainwright
01/19/22 Barclays
Pacira price target raised to $96 from $92 at Barclays
01/07/22 H.C. Wainwright
Pacira reported 'solid' preliminary Q4 sales, says H.C. Wainwright
BTCY Biotricity
$1.35 /

-0.05 (-3.57%)

03/07/22 Lake Street
Biotricity initiated with a Buy at Lake Street
11/23/21 H.C. Wainwright
Biotricity initiated with a Buy at H.C. Wainwright
TWTR Twitter
$36.42 /

-0.32 (-0.87%)

TSM TSMC
$82.57 /

+1.3 (+1.60%)

THTX Theratechnologies
$2.29 /

+0.24 (+11.71%)

PCRX Pacira
$51.83 /

-2.19 (-4.05%)

MSFT Microsoft
$251.34 /

-1.37 (-0.54%)

MS Morgan Stanley
$74.61 /

-0.32 (-0.43%)

JPM JPMorgan
$107.85 /

-4.135 (-3.69%)

ILPT Industrial Logistics Property Trust
$10.66 /

-3.38 (-24.07%)

GRBK Green Brick
$23.55 /

+1.83 (+8.43%)

GOEV Canoo
$4.59 /

+1.005 (+28.07%)

FFIV F5 Networks
$145.47 /

-4.09 (-2.73%)

ERIC Ericsson
$6.84 /

-0.655 (-8.74%)

DG Dollar General
$247.82 /

+1.28 (+0.52%)

DB Deutsche Bank
$7.70 /

-0.105 (-1.35%)

CTAS Cintas
$383.87 /

+5.555 (+1.47%)

CS Credit Suisse
$5.15 /

-0.22 (-4.10%)

COST Costco
$504.42 /

+12.09 (+2.46%)

CAG Conagra Brands
$32.88 /

-2.84 (-7.95%)

BTCY Biotricity
$1.35 /

-0.05 (-3.57%)

BP BP
$25.87 /

-1.14 (-4.22%)

BLU Bellus Health
$8.93 /

-1.165 (-11.54%)

ATEC Alphatec
$6.50 /

-0.285 (-4.20%)

AMZN Amazon.com
$109.32 /

-1.09 (-0.99%)

AMD AMD
$77.60 /

+0.12 (+0.15%)

  • 14
    Jul
  • 17
    Dec
  • 15
    Dec
TWTR Twitter
$36.42 /

-0.32 (-0.87%)

TSM TSMC
$82.57 /

+1.3 (+1.60%)

MSFT Microsoft
$251.34 /

-1.37 (-0.54%)

MS Morgan Stanley
$74.61 /

-0.32 (-0.43%)

JPM JPMorgan
$107.85 /

-4.135 (-3.69%)

GOEV Canoo
$4.59 /

+1.005 (+28.07%)

FFIV F5 Networks
$145.47 /

-4.09 (-2.73%)

ERIC Ericsson
$6.84 /

-0.655 (-8.74%)

DB Deutsche Bank
$7.70 /

-0.105 (-1.35%)

CS Credit Suisse
$5.15 /

-0.22 (-4.10%)

COST Costco
$504.42 /

+12.09 (+2.46%)

CAG Conagra Brands
$32.88 /

-2.84 (-7.95%)

BP BP
$25.87 /

-1.14 (-4.22%)

ATEC Alphatec
$6.50 /

-0.285 (-4.20%)

AMZN Amazon.com
$109.32 /

-1.09 (-0.99%)

AMD AMD
$77.60 /

+0.12 (+0.15%)

TWTR Twitter
$36.42 /

-0.32 (-0.87%)

TSM TSMC
$82.57 /

+1.3 (+1.60%)

PCRX Pacira
$51.83 /

-2.19 (-4.05%)

MSFT Microsoft
$251.34 /

-1.37 (-0.54%)

JPM JPMorgan
$107.85 /

-4.135 (-3.69%)

GRBK Green Brick
$23.55 /

+1.83 (+8.43%)

GOEV Canoo
$4.59 /

+1.005 (+28.07%)

FFIV F5 Networks
$145.47 /

-4.09 (-2.73%)

ERIC Ericsson
$6.84 /

-0.655 (-8.74%)

DG Dollar General
$247.82 /

+1.28 (+0.52%)

DB Deutsche Bank
$7.70 /

-0.105 (-1.35%)

CS Credit Suisse
$5.15 /

-0.22 (-4.10%)

COST Costco
$504.42 /

+12.09 (+2.46%)

CAG Conagra Brands
$32.88 /

-2.84 (-7.95%)

BP BP
$25.87 /

-1.14 (-4.22%)

AMZN Amazon.com
$109.32 /

-1.09 (-0.99%)

AMD AMD
$77.60 /

+0.12 (+0.15%)

TWTR Twitter
$36.42 /

-0.32 (-0.87%)

TSM TSMC
$82.57 /

+1.3 (+1.60%)

TGA TransGlobe
$3.39 /

+0.21 (+6.60%)

MSFT Microsoft
$251.34 /

-1.37 (-0.54%)

MS Morgan Stanley
$74.61 /

-0.32 (-0.43%)

JPM JPMorgan
$107.85 /

-4.135 (-3.69%)

GOEV Canoo
$4.59 /

+1.005 (+28.07%)

FFIV F5 Networks
$145.47 /

-4.09 (-2.73%)

ERIC Ericsson
$6.84 /

-0.655 (-8.74%)

DG Dollar General
$247.82 /

+1.28 (+0.52%)

DB Deutsche Bank
$7.70 /

-0.105 (-1.35%)

CS Credit Suisse
$5.15 /

-0.22 (-4.10%)

COST Costco
$504.42 /

+12.09 (+2.46%)

BP BP
$25.87 /

-1.14 (-4.22%)

AMZN Amazon.com
$109.32 /

-1.09 (-0.99%)

AMD AMD
$77.60 /

+0.12 (+0.15%)

Earnings
Biotricity reports Q4 adjusted EPS (11c), two est. (11c) » 08:27
07/14/22
07/14
08:27
07/14/22
08:27
BTCY

Biotricity

$1.38 /

+0.03 (+2.22%)

Reports Q4 revenue…

Reports Q4 revenue $2.15M, consensus $2.04M. Waqaas Al-Siddiq, Founder & CEO of Biotricity, commented, "Fiscal 2022 was a pivotal year for Biotricity as we made significant strides in our product development and commercialization strategy. Despite Covid headwinds, we were able to continue to grow. We are pleased with year-over-year revenue growth of 81% for the fiscal quarter and 126% for the fiscal year ended March 31, and our gross margin expansion during both periods, primarily driven by our lead product, Bioflux. With the launch of Biotres and Bioheart we are excited to roll out our all-in-one go-to ecosystem solution for cardiac diagnostics and disease management. Cardiologists will now have a comprehensive suite of products available for their patients all within one portal."

ShowHide Related Items >><<
BTCY Biotricity
$1.38 /

+0.03 (+2.22%)

BTCY Biotricity
$1.38 /

+0.03 (+2.22%)

03/07/22 Lake Street
Biotricity initiated with a Buy at Lake Street
11/23/21 H.C. Wainwright
Biotricity initiated with a Buy at H.C. Wainwright
BTCY Biotricity
$1.38 /

+0.03 (+2.22%)

Earnings
Biotricity reports Q4 EPS (11c), two estimates (11c) » 08:10
07/14/22
07/14
08:10
07/14/22
08:10
BTCY

Biotricity

$1.38 /

+0.03 (+2.22%)

Reports Q4 revenue…

Reports Q4 revenue $2.15M, consensus $2.04M.

ShowHide Related Items >><<
BTCY Biotricity
$1.38 /

+0.03 (+2.22%)

BTCY Biotricity
$1.38 /

+0.03 (+2.22%)

03/07/22 Lake Street
Biotricity initiated with a Buy at Lake Street
11/23/21 H.C. Wainwright
Biotricity initiated with a Buy at H.C. Wainwright
Over a quarter ago
Hot Stocks
Biotricity to join Russell Microcap Index » 08:22
06/23/22
06/23
08:22
06/23/22
08:22
BTCY

Biotricity

$1.13 /

-0.02 (-1.74%)

Biotricity announced that…

Biotricity announced that the Company is expected to join the Russell Microcap Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the US market opens on June 27, 2022.

ShowHide Related Items >><<
BTCY Biotricity
$1.13 /

-0.02 (-1.74%)

BTCY Biotricity
$1.13 /

-0.02 (-1.74%)

03/07/22 Lake Street
Biotricity initiated with a Buy at Lake Street
11/23/21 H.C. Wainwright
Biotricity initiated with a Buy at H.C. Wainwright
07/01/21 Northland
Biotricity initiated with an Outperform at Northland
Hot Stocks
Biotricity to join the Russell Microcap Index effective June 27 » 08:17
06/23/22
06/23
08:17
06/23/22
08:17
BTCY

Biotricity

$1.13 /

-0.02 (-1.74%)

Biotricity announced that…

Biotricity announced that the Company is expected to join the Russell Microcap Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective after the US market opens on June 27.

ShowHide Related Items >><<
BTCY Biotricity
$1.13 /

-0.02 (-1.74%)

BTCY Biotricity
$1.13 /

-0.02 (-1.74%)

03/07/22 Lake Street
Biotricity initiated with a Buy at Lake Street
11/23/21 H.C. Wainwright
Biotricity initiated with a Buy at H.C. Wainwright
07/01/21 Northland
Biotricity initiated with an Outperform at Northland
Hot Stocks
Biotricity issues shareholder update » 09:42
05/05/22
05/05
09:42
05/05/22
09:42
BTCY

Biotricity

$1.54 /

+ (+0.00%)

Biotricity provided an…

Biotricity provided an update for its shareholders by Chief Executive Officer Waqaas Al-Siddiq, Ph.D., that discusses recent Company achievements and strategic initiatives to position the business for strong 2022 results, increasing scale and accelerating growth into 2023. In the last 6 months, the Company has achieved several important milestones including: Listing of the Nasdaq, which has elevated Biotricity's stature within its industry while raising its visibility with analysts and institutional investors. Biotricity was named one of the "Fast Company" World's 50 Most Innovative Companies for 2022, and #1 in the medical devices category, joining the ranks of innovators like SpaceX, Canva, and Microsoft. Received FDA clearance and commercially launched its Biotres Cardiac Monitoring Device, expanding our TAM to $8B and evolving Biotricity from a one-product company to a rapidly growing platform covering the spectrum of consumer, patient and physician needs. Launched Biotricity's Bioheart device; Increased our TAM from $1B to $25B; Presented at the 34th annual Roth Conference, one of the largest investment conferences in the nation for small-cap companies. Successfully completed a $12 million non-dilutive debt financing. Posted 93% YOY revenue growth to $1.93 million in the third quarter ended Dec. 31, 2021; Demonstrating scalability, revenue outpaced the SG&A increase by 2.2x; Reported highest ever quarterly cash position at $16.8 million. The company has a number of milestones planned for the rest of the year: Sales force expansion; Continued roll out and expansion of its new complementary products; Strengthening the Board of Directors to align with the company's current status. As Covid / Omicron fades, Biotricity's growing professional sales force is now in 27 states increasing its in-office visits to hospitals and cardiac clinics to demonstrate its state-of-the-art Bioflux high-precision, single-unit mobile cardiac telemetry device as well as to introduce our Biocare Telemed virtual clinic platform which is slated for launch in the second half of 2022. These complement the Company's Bioheart and Biotres devices - targeted to patients and health-conscious consumers - with Biotres just now beginning to enter commercialization. With its consumer-targeted devices, Biotricity's marketing team is efficiently testing and building its omnichannel marketing programs for messaging and return on investment. On the technology side, Biotricity continues to combine artificial intelligence with data and predictive capabilities to create better and faster analytics for preventative patient monitoring and lifestyle management. Ultimately, we aim to become the largest complex cardiac cloud platform spanning diagnostics, disease, and lifestyle management.

ShowHide Related Items >><<
BTCY Biotricity
$1.54 /

+ (+0.00%)

BTCY Biotricity
$1.54 /

+ (+0.00%)

03/07/22 Lake Street
Biotricity initiated with a Buy at Lake Street
11/23/21 H.C. Wainwright
Biotricity initiated with a Buy at H.C. Wainwright
07/01/21 Northland
Biotricity initiated with an Outperform at Northland

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.